Journal Article DKFZ-2017-01862

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2016
Elsevier Science Amsterdam [u.a.]

Cancer letters 371(2), 326 - 333 () [10.1016/j.canlet.2015.11.037]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: Within primary colorectal cancer (CRC) a subfraction of all tumor-initiating cells (TIC) drives long-term progression in serial xenotransplantation. It has been postulated that efficient maintenance of TIC activity in vitro requires serum-free spheroid culture conditions that support a stem-like state of CRC cells. To address whether tumorigenicity is indeed tightly linked to such a stem-like state in spheroids, we transferred TIC-enriched spheroid cultures to serum-containing adherent conditions that should favor their differentiation. Under these conditions, primary CRC cells did no longer grow as spheroids but formed an adherent cell layer, up-regulated colon epithelial differentiation markers, and down-regulated TIC-associated markers. Strikingly, upon xenotransplantation cells cultured under either condition equally efficient formed serially transplantable tumors. Clonal analyses of individual lentivirally marked TIC clones cultured under either culture condition revealed no systematic differences in contributing clone numbers, indicating that phenotypic differentiation does not select for few individual clones adapted to unfavorable culture conditions. Our results reveal that CRC TIC can be propagated under conditions previously thought to induce their elimination. This phenotypic plasticity allows addressing primary human CRC TIC properties in experimental settings based on adherent cell growth.

Keyword(s): Biomarkers, Tumor

Classification:

Contributing Institute(s):
  1. Biostatistik (C060)
  2. Angewandte Funktionelle Genomik (G102)
  3. Translationale Onkologie (G100)
  4. DKTK Heidelberg (L101)
  5. Molekulare Therapie in der Hämatologie und Onkologie (G250)
  6. DKTK München (L701)
Research Program(s):
  1. 317 - Translational cancer research (POF3-317) (POF3-317)

Appears in the scientific report 2016
Database coverage:
Medline ; BIOSIS Previews ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2017-08-29, last modified 2024-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)